Answers are grounded in this paper and cite their sources.
We investigated the feasibility of using HeLa cells, a continuous cell line from human cervical carcinoma, as targets in in vitro microcy,totoxicity assays for ceIl-mediated immunity in patients with invasive or preinvasive carcinoma of the uterine cervix. The purified lymphocytes of 16 of 24 (67%) patients with invasive carcinoma and 14 of 27 (52%) with carcinoma in situ or severe epithelial dysplasia were cytotoxic against HeLa cells but not against target cells from an established line of human amnion grown for a comparable period in vitro. No specific HeLa cell cytotoxicity was found in patients with carcinoma of the uterine corpus or epidermoid carcinoma of the larynx nor among healthy controls. Sera could block the cell-mediated cytotoxicity in 50% of the 15 patients tested; this blocking occurred equally in both the preinvasive and invasive carcinomas. The results suggest that the HeLa cell line still carries tumor-specific surface antigens, which might be applied to the immunodiagnosis of human cervical cardnoma.
No takes yet. Share an insight, caveat, or question.
Saksela et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: